Marcaban, Baby Boy -.
HRN: 22-06-93 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/24/2022
10/31/2022
IVT
21 Mg
24 Hrs
ER Delivery
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes